Endo Pharma (Nasdaq: ENDP) shares are nosediving this hour as we are hearing that a Citi analyst has just ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE